Cargando…
Structure‐Activity Relationship of Phenylpyrazolones against Trypanosoma cruzi
Chagas disease is a neglected parasitic disease caused by the parasitic protozoan Trypanosoma cruzi and currently affects around 8 million people. Previously, 2‐isopropyl‐5‐(4‐methoxy‐3‐(pyridin‐3‐yl)phenyl)‐4,4‐dimethyl‐2,4‐dihydro‐3H‐pyrazol‐3‐one (NPD‐0227) was discovered to be a sub‐micromolar i...
Autores principales: | Sijm, Maarten, Sterk, Geert Jan, Caljon, Guy, Maes, Louis, de Esch, Iwan J. P., Leurs, Rob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496920/ https://www.ncbi.nlm.nih.gov/pubmed/32249532 http://dx.doi.org/10.1002/cmdc.202000136 |
Ejemplares similares
-
Identification of Phenylpyrazolone Dimers as a New Class of Anti‐Trypanosoma cruzi Agents
por: Sijm, Maarten, et al.
Publicado: (2019) -
Structure Activity Relationship of N-Substituted Phenyldihydropyrazolones Against Trypanosoma cruzi Amastigotes
por: Sijm, Maarten, et al.
Publicado: (2021) -
Structural Optimization of BIPPO Analogs as Potent Antimalarials
por: Zheng, Yang, et al.
Publicado: (2023) -
Development of Novel Isoindolone‐Based Compounds against Trypanosoma brucei rhodesiense
por: Silva, Daniel G., et al.
Publicado: (2021) -
3-nitroimidazo[1,2-b]pyridazine as a novel scaffold for antiparasitics with sub-nanomolar anti-Giardia lamblia activity
por: Zheng, Yang, et al.
Publicado: (2022)